tiprankstipranks
AEON Biopharma (AEON)
XASE:AEON
US Market
AEON
AEON Biopharma
RESEARCH TOOLSreports

AEON Biopharma (AEON) Income Statement

223 Followers

AEON Biopharma Income Statement

Last quarter (Q4 2025), AEON Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, AEON Biopharma's net income was $-37.14M. See AEON Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -78.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 16.82M$ -72.98M$ 348.09M$ 48.43M$ 65.85M
Depreciation and Amortization
$ 78.00K$ 97.00K$ 99.00K$ 68.00K$ 3.00K
EBITDA
$ -16.82M$ -27.73M$ -52.74M$ -48.36M$ -36.88M
Operating Income
$ -16.90M$ 72.98M$ -348.09M$ -48.43M$ -65.85M
Other Income/Expenses
$ -22.32M$ -30.98M$ -36.55M$ -4.13M$ 10.21M
Pretax Income
$ -39.22M$ 42.01M$ -384.63M$ -52.56M$ -55.64M
Net Income
$ -39.22M$ 42.01M$ -384.63M$ -52.56M$ -55.64M
Per Share Metrics
Basic EPS
$ -3.95$ 77.74$ -4.99$ -27.25$ -31.73
Diluted EPS
$ -3.95$ 72.93$ -4.99$ -27.25$ -31.73
Weighted Average Shares Outstanding
 9.92M 575.00K 77.07M 1.93M 1.75M
Weighted Average Shares Outstanding (Diluted)
 9.92M 575.95K 77.07M 1.93M 1.75M
Currency in USD

AEON Biopharma Earnings and Revenue History